Ingalls & Snyder’s CAS Medical Systems CASM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-293,336
Closed -$713K – 437
2019
Q1
$713K Sell
293,336
-173,536
-37% -$373K 0.03% 248
2018
Q4
$747K Sell
466,872
-34,191
-7% -$63.7K 0.04% 239
2018
Q3
$1.14M Buy
+501,063
New +$1.07M 0.05% 212

Ingalls & Snyder's CASM Position: Q2 2019 in Review

Ingalls & Snyder sold out of CAS Medical Systems (CASM) in Q2 2019, closing a stake of 293,336 shares — an estimated $713K sold.

Ingalls & Snyder first reported a position in CASM in Q3 2018 and held it in 3 quarters. The position peaked at $1.14M in Q3 2018. 0 funds tracked by Wall St. Rank hold CASM as of Q2 2019.

  • Ingalls & Snyder reported no remaining CAS Medical Systems position as of Q2 2019 after selling out during the quarter.
  • Ingalls & Snyder sold 293,336 CAS Medical Systems shares in Q2 2019, an estimated $713K.
  • Ingalls & Snyder first reported a position in CAS Medical Systems in Q3 2018 and held it in 3 quarters.
  • Ingalls & Snyder's CAS Medical Systems position peaked at $1.14M in Q3 2018.
  • 0 funds tracked by Wall St. Rank held CAS Medical Systems as of Q2 2019.

Based on Ingalls & Snyder's 13F filing for Q2 2019, filed 11 Jul 2019.